Enzalutamide

Mechanism of action:

Antagonist of the androgen receptor (the biological target of androgens like testosterone and dihydrotestosterone )

Indications:

metastatic castration-resistant prostate cancer (mCRPC) and nonmetastatic castration-resistant prostate cancer.

Chemical Name:

4-[3-[4-cyano-3-(trifluoromethyl) phenyl]-5,5-dimethyl-4-oxo-2-thioxo-1-imidazolidinyl]-2-fluoro-N-methyl-benzamide

Details

464.4 g/mol

C₂₁H₁₆F₄N₄O₂S

915087-33-1

Powder

Enzalutamide